Amyloid, Hyperactivity, and Metabolism: Theoretical Comment on Vloeberghs et al. (2008)

Behavioral Neuroscience

Volumn 122, Issue 3, 2008, Pages 730-732

  Morgan, Dave ^a   Gordon, Marcia N ^a  

^a UNIVERSITY OF NOTTINGHAM MALAYSIA CAMPUS   (Malaysia)

Author keywords

activity; Alzheimer's disease; amyloid; body weight; hypermetabolism

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BASAL METABOLIC RATE; CELL MEMBRANE TRANSPORT; HYPERACTIVITY; HYPERMETABOLISM; LOCOMOTION; NEUROPATHOLOGY; NONHUMAN; TRANSGENIC MOUSE; WEIGHT REDUCTION;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; DISEASE MODELS, ANIMAL; HYPERKINESIS; METABOLISM; MICE;

EID: 44649110724     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.122.3.730     Document Type: Article

References (36)

1. Adriani W., Ognibene E., Heuland E., Ghirardi O., Caprioli A., and Laviola G. Motor impulsivity in APP-SWE mice: A model of Alzheimer's disease. Behavioural Pharmacology 17 (2006) 525-533
2. Atamna H., and Frey W.H. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease. Mitochondrion 7 (2007) 297-310
3. Baloyannis S.J. Mitochondrial alterations in Alzheimer's disease. Journal of Alzheimer's Disease 9 (2006) 119-126
4. Bhatia R., Lin H., and Lal R. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: Evidence for AbetaP channel-mediated cellular toxicity. FASEB Journal 14 (2000) 1233-1243
5. Bosaeus I., Daneryd P., and Lundholm K. Dietary intake, resting energy expenditure, weight loss and survival in cancer patients. Journal of Nutrition 132 (2002) 3465S-3466S
6. Buchman A.S., Wilson R.S., Bienias J.L., Shah R.C., Evans D.A., and Bennett D.A. Change in body mass index and risk of incident Alzheimer disease. Neurology 65 (2005) 892-897
7. Carlson G.A., Borchelt D.R., Dake A., Turner S., Danielson V., Coffin J.D., et al. Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Human Molecular Genetics 6 (1997) 1951-1959
8. Clausen T., Van Hardeveld C., and Everts M.E. Significance of cation transport in control of energy metabolism and thermogenesis. Physiological Reviews 71 (1991) 733-774
9. de Jong F.J., den Heijer T., Visser T.J., de Rijke Y.B., Drexhage H.A., Hofman A., and Breteler M.M. Thyroid hormones, dementia, and atrophy of the medial temporal lobe. Journal of Clinical Endocrinology and Metabolism 91 (2006) 2569-2573
10. Dickey C.A., Gordon M.N., Wilcock D.M., Herber D.L., Freeman M.J., Barcenas M., and Morgan D. Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice. BMC Neuroscience 6 (2005) 7
11. Dodart J.C., Meziane H., Mathis C., Bales K.R., Paul S.M., and Ungerer A. Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behavioral Neuroscience 113 (1999) 982-990
12. Etcheberrigaray R., Tan M., Dewachter I., Kuiperi C., Van der Auwera I., Wera S., et al. Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice. Proceedings of the National Academy of Sciences, USA 101 (2004) 11141-11146
13. Flood D.G., Reaume A.G., Dorfman K.S., Lin Y.G., Lang D.M., Trusko S.P., et al. FAD mutant PS-1 gene-targeted mice: Increased A beta 42 and A beta deposition without APP overproduction. Neurobiology of Aging 23 (2002) 335-348
14. Gillette G.S., Abellan V.K., Alix E., Andrieu S., Belmin J., Berrut G., et al. IANA (International Academy on Nutrition and Aging) Expert Group: Weight loss and Alzheimer's disease. Journal of Nutrition, Health and Aging 11 (2007) 38-48
15. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., and Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: Lack of association with amyloid deposits. Behavior Genetics 29 (1999) 177-185
16. Holcomb L.A., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Medicine 4 (1998) 97-100
17. Hulbert A.J., and Else P.L. Basal metabolic rate: History, composition, regulation, and usefulness. Physiological and Biochemical Zoology 77 (2004) 869-876
18. Kayed R., Sokolov Y., Edmonds B., McIntire T.M., Milton S.C., Hall J.E., and Glabe C.G. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. Journal of Biological Chemistry 279 (2004) 46363-46366
19. Mark R.J., Hensley K., Butterfield D.A., and Mattson M.P. Amyloid beta-peptide impairs ion-motive ATPase activities: Evidence for a role in loss of neuronal Ca2+ homeostasis and cell death. Journal of Neuroscience 15 (1995) 6239-6249
20. McLaurin J., Kierstead M.E., Brown M.E., Hawkes C.A., Lambermon M.H., Phinney A.L., et al. Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nature Medicine 12 (2006) 801-808
21. Moreira P.I., Cardoso S.M., Santos M.S., and Oliveira C.R. The key role of mitochondria in Alzheimer's disease. Journal of Alzheimer's Disease 9 (2006) 101-110
22. Ohno M., Sametsky E.A., Younkin L.H., Oakley H., Younkin S.G., Citron M., et al. BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41 (2004) 27-33
23. Parihar M.S., and Brewer G.J. Mitoenergetic failure in Alzheimer disease. American Journal of Physiology-Cell Physiology 292 (2007) C8-23
24. Patel N.V., Gordon M.N., Connor K.E., Good R.A., Engelman R.W., Mason J., et al. Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiology of Aging 26 (2005) 995-1000
25. Pedersen W.A., Culmsee C., Ziegler D., Herman J.P., and Mattson M.P. Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease. Journal of Molecular Neuroscience 13 (1999) 159-165
26. Pereira C.T., and Herndon D.N. The pharmacologic modulation of the hypermetabolic response to burns. Advances in Surgery 39 (2005) 245-261
27. Poehlman E.T., Toth M.J., Goran M.I., Carpenter W.H., Newhouse P., and Rosen C.J. Daily energy expenditure in free-living non-institutionalized Alzheimer's patients: A doubly labeled water study. Neurology 48 (1997) 997-1002
28. Pugh P.L., Richardson J.C., Bate S.T., Upton N., and Sunter D. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behavioural Brain Research 178 (2007) 18-28
29. Schols A. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease. Proceedings of the Nutrition Society 62 (2003) 783-791
30. Stewart R., Masaki K., Xue Q.L., Peila R., Petrovitch H., White L.R., and Launer L.J. A 32-year prospective study of change in body weight and incident dementia: The Honolulu-Asia Aging Study. Archives of Neurology 62 (2005) 55-60
31. Touma C., Ambree O., Gortz N., Keyvani K., Lewejohann L., Palme R., et al. Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer's disease. Neurobiology of Aging 25 (2004) 893-904
32. Trager K., DeBacker D., and Radermacher P. Metabolic alterations in sepsis and vasoactive drug-related metabolic effects. Current Opinion in Critical Care 9 (2003) 271-278
33. Vloeberghs E., Van Dam D., Engelborghs S., Nagels G., Staufenbiel M., and De Deyn P.P. Altered circadian locomotor activity in APP23 mice: A model for BPSD disturbances. European Journal of Neuroscience 20 (2004) 2757-2766
34. Vloeberghs E., Van Dam D., Franck F., Serroyen J., Geert M., Staufenbiel M., et al. Altered ingestive behavior, weight changes, and intact olfactory sense in an APP overexpression model. Behavioral Neuroscience 122 (2008) 491-497
35. White H.K., McConnell E.S., Bales C.W., and Kuchibhatla M. A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer's disease subjects. Journal of the American Medical Directors Association 5 (2004) 89-97
36. Zhang C., McNeil E., Dressler L., and Siman R. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease. Experimental Neurology 204 (2007) 77-87